[HTML][HTML] Cannabis-based medicines and medical cannabis for chronic neuropathic pain

F Petzke, T Tölle, MA Fitzcharles, W Häuser - CNS drugs, 2022 - Springer
Neuropathic pain represents a broad category of pain syndromes that include a wide variety
of peripheral and central disorders. The overall prevalence of neuropathic pain in the …

[HTML][HTML] The efficacy of cannabis on multiple sclerosis-related symptoms

F Haddad, G Dokmak, R Karaman - Life, 2022 - mdpi.com
Multiple sclerosis (MS) is known as an autoimmune disease that damages the neurons in
the central nervous system. MS is characterized by its most common symptoms of spasticity …

[HTML][HTML] Therapeutic potential of cannabis: a comprehensive review of current and future applications

ZJ Leinen, R Mohan, LS Premadasa, A Acharya… - Biomedicines, 2023 - mdpi.com
Historically, cannabis has been valued for its pain-relieving, anti-inflammatory, and calming
properties. Ancient civilizations like the Egyptians, Greeks, and Chinese medicines …

[HTML][HTML] A large Australian longitudinal cohort registry demonstrates sustained safety and efficacy of oral medicinal cannabis for at least two years

AW Vickery, S Roth, T Ernenwein, J Kennedy… - PLoS one, 2022 - journals.plos.org
Introduction Oral medicinal cannabis (MC) has been increasingly prescribed for a wide
range of clinical conditions since 2016. Despite an exponential rise in prescriptions and …

[HTML][HTML] Combination therapy for neuropathic pain: a review of recent evidence

A Serrano Afonso, T Carnaval… - Journal of Clinical …, 2021 - mdpi.com
Pharmacological treatment is not very effective for neuropathic pain (NP). A progressive
decrease in the estimated effect of NP drugs has been reported, giving rise to an increase in …

Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence

E Sokolaj, N Assareh, K Anderson… - Journal of …, 2023 - Wiley Online Library
Chronic neuropathic pain is a debilitating pain syndrome caused by damage to the nervous
system that is poorly served by current medications. Given these problems, clinical studies …

[HTML][HTML] CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders–Results of a prospective, multicenter, randomized …

KR Müller-Vahl, A Pisarenko, N Szejko, M Haas… - Psychiatry …, 2023 - Elsevier
Preliminary data suggest that cannabis-based medicines might be a promising new
treatment for patients with Tourette syndrome (TS)/chronic tic disorders (CTD) resulting in an …

Comparison of the effectiveness and tolerability of nabiximols (THC: CBD) oromucosal spray versus oral dronabinol (THC) as add-on treatment for severe neuropathic …

MA Ueberall, U Essner, C Vila Silván… - Journal of Pain …, 2022 - Taylor & Francis
Purpose To compare the effectiveness and tolerability of add-on treatment with nabiximols
(NBX: delta-9-tetrahydrocannabinol: cannabidiol) oromucosal spray or oral dronabinol …

[HTML][HTML] Tetrahydrocannabinol and Cannabidiol for Pain Treatment—An Update on the Evidence

K Safi, J Sobieraj, M Błaszkiewicz, J Żyła, B Salata… - Biomedicines, 2024 - mdpi.com
In light of the current International Association for the Study of Pain (IASP) clinical practice
guidelines (CPGs) and the European Society for Medical Oncology (ESMO) guidelines, the …

[HTML][HTML] Combinations of Cannabidiol and Δ9-Tetrahydrocannabinol in Reducing Chemotherapeutic Induced Neuropathic Pain

DE Sepulveda, KE Vrana, NM Graziane… - Biomedicines, 2022 - mdpi.com
Neuropathic pain is a condition that impacts a substantial portion of the population and is
expected to affect a larger percentage in the future. This type of pain is poorly managed by …